Evaluation of a decision aid for families considering p53 genetic counseling and testing

Genet Med. 2006 Apr;8(4):226-33. doi: 10.1097/01.gim.0000214632.52958.01.

Abstract

Purpose: Li-Fraumeni syndrome (LFS) is associated with p53 germline mutations, and carriers are at increased risk for multiple primary cancers. We evaluated outcomes following the administration of a video-based decision aid (DA) prior to clinical p53 genetic counseling and testing among persons who had previously participated in cancer genetics research.

Methods: Fifty-seven individuals at risk for a known p53 mutation completed baseline and post-DA measures of psychological outcomes, plus knowledge and attitudes regarding p53 genetic testing. Counseling and testing uptake also was recorded.

Results: At baseline, multivariate analysis showed that greater testing intention was associated with lower decisional conflict (P < 0.01). Compared with baseline data, multivariate analyses of post-DA outcomes showed that knowledge about LFS and genetic testing increased and decisional conflict related to testing decreased (P < 0.001). Mean cancer worries scores decreased among all participants (P < 0.001), and mean depression scores decreased for males (P < 0.05). Thirty-nine (68%) completed pre-test genetic counseling and 23 (40%) subsequently gave a blood sample for clinical genetic testing.

Conclusion: This intervention was useful as an initial outreach and educational method for families considering p53 genetic testing, and may improve knowledge about LFS as well as psychological outcomes.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Decision Making*
  • Decision Support Techniques*
  • Family / psychology*
  • Female
  • Genetic Counseling / psychology*
  • Genetic Predisposition to Disease / psychology
  • Genetic Testing / psychology*
  • Humans
  • Li-Fraumeni Syndrome / genetics
  • Li-Fraumeni Syndrome / prevention & control
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mutation
  • Outcome Assessment, Health Care
  • Patient Participation
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Tumor Suppressor Protein p53